<prompt>  An experimental drug is found to preferentially dilate autoregulatory coronary arterioles without affecting large conducting vessels. It is likely to:Evoke coronary steal phenomenonMitigate classical angina but not variant anginaProduce tachycardia as an adverse effectUseful in CHF 